Browsing Faculty of Health Sciences (FHS) by Author "04d74731-b40a-4e4d-b388-3bf96d22b143"
Now showing items 1-3 of 3
-
Frequency of monitoring kidney function in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis.
Mugwanya, KK; Baeten, JM; Mugo, NR; Celum, CL; Ronald, A; Kiarie, J; Katabira, E; Heffron, R (University of Nairobi, 2017)BACKGROUND: Wide-scale implementation of oral tenofovir-based pre-exposure prophylaxis (PrEP) for HIV prevention is now policy in many settings. However, the optimal frequency for monitoring kidney function remains ... -
Low risk of proximal tubular dysfunction associated with emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis in men and women.
Mugwanya, K; Baeten, J; Celum, C; Donnell, D; Nickolas, T; Mugo, N; Branch, A; Tappero, J; Kiarie, J; Ronald, A; Yin, M; Wyatt, C. (University of Nairobi, 2016)OBJECTIVE: Tenofovir disoproxil fumarate (TDF) is associated with proximal tubular dysfunction (tubulopathy) when used in the treatment of human immunodeficiency virus (HIV) infection. We evaluated whether TDF causes ... -
Low risk of proximal tubular dysfunction associated with emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis in men and women.
Mugwanya, K; Baeten, J; Celum, C; Donnell, D; Nickolas, T; Mugo, N; Branch, A; Tappero, J; Kiarie, J; Ronald, A; Yin, M; Wyatt, C (University of Nairobi, 2016)OBJECTIVE: Tenofovir disoproxil fumarate (TDF) is associated with proximal tubular dysfunction (tubulopathy) when used in the treatment of human immunodeficiency virus (HIV) infection. We evaluated whether TDF causes ...